521 related articles for article (PubMed ID: 11214225)
1. Hypercalcemia of malignancy--new insights into an old syndrome.
Esbrit P
Clin Lab; 2001; 47(1-2):67-71. PubMed ID: 11214225
[TBL] [Abstract][Full Text] [Related]
2. [Malignancy-associated hypercalcemia].
Yamaguchi K
Gan To Kagaku Ryoho; 1991 Mar; 18(3):343-9. PubMed ID: 2003737
[TBL] [Abstract][Full Text] [Related]
3. [PTHrP and breast cancer].
Devys A; Lortholary A; Audran M
Bull Cancer; 2001 Nov; 88(11):1075-80. PubMed ID: 11741801
[TBL] [Abstract][Full Text] [Related]
4. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
Sato K; Yamakawa Y; Shizume K; Satoh T; Nohtomi K; Demura H; Akatsu T; Nagata N; Kasahara T; Ohkawa H
J Bone Miner Res; 1993 Jul; 8(7):849-60. PubMed ID: 8352067
[TBL] [Abstract][Full Text] [Related]
5. Humoral hypercalcemia of malignancy. The role of parathyroid hormone-related protein.
Insogna KL
Endocrinol Metab Clin North Am; 1989 Sep; 18(3):779-94. PubMed ID: 2673773
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
7. A novel parathyroid hormone-related protein: role in pathology and physiology.
Martin TJ; Ebeling PR
Prog Clin Biol Res; 1990; 332():1-37. PubMed ID: 2184438
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of parathyroid hormone-related protein fragments in patients with humoral hypercalcemia of malignancy and hypercalcemic tumor-bearing nude mice.
Imamura H; Sato K; Shizume K; Satoh T; Kasono K; Ozawa M; Ohmura E; Tsushima T; Demura H
J Bone Miner Res; 1991 Jan; 6(1):77-84. PubMed ID: 2048434
[TBL] [Abstract][Full Text] [Related]
9. [Malignant humoral hypercalcemia and the parathyroid hormone related protein].
Jemtland R; Rian E; Gautvik KM
Tidsskr Nor Laegeforen; 1991 May; 111(14):1738-42. PubMed ID: 2063384
[TBL] [Abstract][Full Text] [Related]
10. [Cytokines in bone diseases. Cytokines and malignancy-associated hypercalcemia].
Okazaki R
Clin Calcium; 2010 Oct; 20(10):1497-502. PubMed ID: 20890031
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of cancer-induced hypercalcemia.
Rosol TJ; Capen CC
Lab Invest; 1992 Dec; 67(6):680-702. PubMed ID: 1460860
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone-related protein-(1--36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy.
Syed MA; Horwitz MJ; Tedesco MB; Garcia-Ocaña A; Wisniewski SR; Stewart AF
J Clin Endocrinol Metab; 2001 Apr; 86(4):1525-31. PubMed ID: 11297578
[TBL] [Abstract][Full Text] [Related]
13. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.
Burtis WJ; Brady TG; Orloff JJ; Ersbak JB; Warrell RP; Olson BR; Wu TL; Mitnick ME; Broadus AE; Stewart AF
N Engl J Med; 1990 Apr; 322(16):1106-12. PubMed ID: 2320080
[TBL] [Abstract][Full Text] [Related]
15. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
[TBL] [Abstract][Full Text] [Related]
16. Hypercalcemia of cancer: an update.
Goni MH; Tolis G
Anticancer Res; 1993; 13(4):1155-60. PubMed ID: 8352538
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
18. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms and treatment of hypercalcemia of malignancy.
Clines GA
Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]